AIMT


Nestlé Launches $2.6B Tender Offer For Aimmune Therapeutics

Nestlé S.A.

3 Healthcare Stocks With Huge FDA Decisions in January

In the stock market, sometimes all it takes is a single catalyst to propel shares to sky-high levels. This is especially common with …

3 “Perfect 10” Energy Stocks to Power Returns

Has the energy sector been reinvigorated? Judging by the XLE Energy ETF’s 6% rally over the last month, some investors think that this …

3 “Strong Buy” Biotech Stocks Ahead of FDA Verdicts

Most biotech stocks have been under pressure recently, but as we approach the end of the year, many analysts are quite bullish as …

4 Notable Analyst Calls in the Biotech Sector: Loxo Oncology (LOXO), VBL Therapeutics (VBLT), Kalvista Pharmaceuticals (KALV), Aimmune (AIMT)

Investors have been treated like rented mules by the market so far here in October.  More than 75% of the S&P 500 (including …

DBV Technologies’ Pain is Aimmune Therapeutics Inc’s (AIMT) Gain

It’s a very rewarding trading day for Aimmune Therapeutics Inc (NASDAQ:AIMT) investors with shares up over 30%, making the stock Wall Street’s bull …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts